Sees billings $131M-$133M, adjusted contribution $47M-$48M, adjusted EBITDA $9.5M-$10.5M. “I am pleased that we expect to meet or exceed our previous guidance,” said Cardlytics CFO Alexis DeSieno. “Our focus on cost discipline and efficiency is paying off, and our fourth-quarter performance continues to prove that we can achieve sustained profitability. Our preliminary Q4 2023 results also imply positive adjusted EBITDA for 2023. Once finalized, this positive adjusted EBITDA result for 2023 will allow us to extend the maturity date of our credit facility to April 2025 pursuant to the terms of the credit facility agreement, giving us additional flexibility.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CDLX:
- Cardlytics Appoints Two New Members to its Board of Directors
- Cardlytics announces multi-year contract renewal with Lloyds Bank
- Cardlytics Announces Multi-Year Contract Renewal with Lloyds Bank Plc
- Kigo, an Augeo subsidiary, acquires Entertainment® to advance Open Loyalty™ innovation & elevate digital offer experiences
- Cardlytics initiated with a Buy at Lake Street